caricel 2 mg - 30 mcg comprimidos recubiertos
laboratorios leti, s.a.v. - clormadinona - etinilestradiol - comprimidos recubiertos - 2 mg - 30 mcg
gynorelle 2 mg - 0,02 mg comprimidos recubiertos
gynopharm de venezuela, c.a. - acetato de clormadinona - etinilestradiol - comprimido recubierto - 2 mg - 0,02 mg
noal 2 mg - 0,02 mg tabletas recubiertas
grunenthal venezolana farmaceutica, c.a. - hungria - tableta - 2 mg - 0,02 mg
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - agentes antineoplásicos - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
cabometyx 20mg comprimido recubierto
sanofi - aventis del peru s.a. - comprimido recubierto - por comprimido - cabozantinib
cabometyx 60mg comprimido recubierto
sanofi - aventis del peru s.a. - comprimido recubierto - por comprimido - cabozantinib
cabometyx 40mg comprimido recubierto
sanofi - aventis del peru s.a. - comprimido recubierto - por comprimido - cabozantinib
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - agentes antineoplásicos - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
caricel 2 mg - 0,02 mg comprimidos recubiertos
laboratorios leti, s.a.v. - clormadinona - etinilestradiol - comprimidos recubiertos - 2 mg - 0,02 mg
soliris 300 mg vial 30 ml